(1 - 17 von 45
)
Pharma giant Valeant looking more desperate than ever
nypost.com
Irina Koffler, an analyst with Mizuho Securities USA, fretted that Valeant's business is so bad that it may not have any option other than to ...
Mizuho Securities USA Announces Senior US Equity Research Appointment...
www.wallstreet-online.de
... the U.S. investment banking subsidiary of Mizuho Financial Group (NYSE: MFG), has appointed Irina Koffler Managing Director and Senior Analyst leading ...
UPDATE 3-Valeant predicts tough with revenue to decline |
www.kitco.com
"It still doesn't appear that management has a realistic outlook on its organic growth," Mizuho analyst Irina Koffler wrote in a research note.
Valeant CEO out, investor Ackman in over drugmaker's accounting...
www.businessinsurance.com
... weak and eroding, and do not expect a new management team to return the business to growth," Mizuho analyst Irina Koffler wrote in a note.
sortiert nach Relevanz / Datum